Maravai LifeSciences (MRVI) News

Maravai LifeSciences (MRVI): $7.70

0.12 (+1.58%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add MRVI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 359

in industry

Filter MRVI News Items

MRVI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MRVI News Highlights

  • MRVI's 30 day story count now stands at 2.
  • Over the past 24 days, the trend for MRVI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about MRVI are PAY and SAFE.

Latest MRVI News From Around the Web

Below are the latest news stories about MARAVAI LIFESCIENCES HOLDINGS INC that investors may wish to consider to help them evaluate MRVI as an investment opportunity.

Bank of America Pounds the Table on These 3 Buy-Rated Stocks

It’s safe to say now that stock investors are finishing 2023 in a pretty happy mood. We saw large gains in the markets, and even the late-summer swoon has been fully offset by November’s bullish turn, still in play six weeks later. At the start of this year, Bank of America set a year-end target for the S&P 500 at 4,600. The index has surpassed that, and BofA’s equity strategy team is predicting it will hit 5,000 by the end of next year. Commenting on the markets, Savita Subramanian, the bank’s

Yahoo | December 18, 2023

Are Options Traders Betting on a Big Move in Maravai LifeSciences (MRVI) Stock?

Investors need to pay close attention to Maravai LifeSciences (MRVI) stock based on the movements in the options market lately.

Yahoo | November 24, 2023

Analyst Forecasts Just Became More Bearish On Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

One thing we could say about the analysts on Maravai LifeSciences Holdings, Inc. ( NASDAQ:MRVI ) - they aren't...

Yahoo | November 16, 2023

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November. On November 14, 2023, at 10:55 a.m. EST, Trey Martin, Chief Executive Officer (CEO) and Kevin Herde, Chief Financial Officer (CFO), will participate in a fireside chat at the Stifel Healthcare Conference, 2023, being held

Yahoo | November 9, 2023

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2023 Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: Ladies and gentlemen, thank you for standing by. My name is Tammy and I will be your conference operator today. At this time, I would like to welcome everyone to the Third Quarter 2023 Maravai LifeSciences Earnings Conference Call. [Operator Instructions] […]

Yahoo | November 8, 2023

Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript

At this time, I would like to welcome everyone to the third quarter 2023 Maravai LifeSciences earnings conference call. As you can see on the agenda on Slide 2, joining me today are Trey Martin, chief executive officer; and Kevin Herde, chief financial officer; Drew Birch, president of nucleic acid production; and Becky Buzzeo, our executive vice president and chief commercial officer; will join the call for the question-and-answer session following our prepared remarks.

Yahoo | November 8, 2023

Maravai LifeSciences Holdings Inc (MRVI) Reports Q3 2023 Financial Results Amidst Market Realignment

Revenue Declines as Company Announces Cost Reduction Initiatives

Yahoo | November 7, 2023

Maravai LifeSciences Reports Third Quarter 2023 Financial Results

Announces Realignment to Drive Operational Efficiencies and Streamline the Business Post-Pandemic Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2023, together with other busines

Yahoo | November 7, 2023

TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’

SAN DIEGO, November 02, 2023--TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’

Yahoo | November 2, 2023

12 Cheap Biotech Stocks Smart Investors Are Piling Into

In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into. If you want to skip our introduction to the biotechnology industry and how it might be affected by recent economic and stock market trends, then check out 5 Cheap Biotech Stocks Smart Investors Are Piling Into. […]

Yahoo | October 20, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!